Creative Biolabs Oncolytic Virotherapy

Menu

Skip to content
  • Oncolytic Virus Research
  • Oncolytic Virus News

Category Archives: Cancer Immunotherapy

18Feb/24

Combining Oncolytic Viruses with T-cell Therapy Enhances Cancer Treatment

February 18, 2024Cancer Immunotherapy, Oncolytic Virus News, Oncolytic Virus ResearchOncolytic Virus, T-cell Therapybiolabs

In a new study, researchers from Zhejiang University, the Chinese Academy of Sciences, and Xiamen University have developed a novel approach to combat cancerous tumors. The method, named ONCOTECH, combines oncolytic virusRead More…

05Oct/23

Oncolytic Viruses Can Induce A “Cold” Tumor to Heat Up and Improve the Efficiency of Immunotherapy in Treating Cancer

October 5, 2023Cancer Immunotherapy, Oncolytic Virus ResearchImmunotherapy, Oncolytic Virusbiolabs

Although checkpoint blockade therapy has achieved widespread success, it relies on reactive immune infiltration. Therefore, researchers are urgently seeking to develop therapies that enhance immune infiltration and prevent immune suppression. In aRead More…

11Sep/23

The Secrets of Tissue-Resident Memory T Cells in Fighting Infections and Cancer

September 11, 2023Cancer ImmunotherapyCD8+ T cell, Tissue-Resident Memory T Cellbiolabs

The human immune system possesses a remarkable strategy—it remembers past adversaries through a phenomenon known as immunological memory, thus thwarting potential diseases. This credit goes to a specialized cell type called tissue-residentRead More…

11Aug/23

Scientists Reveal a Unique Mechanism of Gene Expression Coordination in Tumors

August 11, 2023Cancer ImmunotherapyCancer Research, CXCL9, tumor microenvironmentbiolabs

The tumor microenvironment (TME) plays a crucial role in cancer progression, and it is highly complex with variations among different patients. In a recent research report published in the international journal ScienceRead More…

28Jul/23

Unveiling the Key Mechanism of p53 in Tumor Suppression

July 28, 2023Cancer Immunotherapyp53, Tumor Suppressionbiolabs

According to the latest data released by the International Agency for Research on Cancer (IARC), there were 19.29 million new cancer cases worldwide in 2020, with 9.96 million new cancer-related deaths. CancerRead More…

27Jun/23

The Role of AXL in Cancer: A Modulator of Drug Resistance and Therapeutic Target

June 27, 2023Cancer ImmunotherapyAXL, Cancer Researchbiolabs

Cancer continues to be a leading cause of death worldwide, with its incidence and burden of mortality steadily on the rise. Despite significant advancements in research and development of cancer treatment strategiesRead More…

18May/23
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma

Novel AAV-Based Immunotherapy May Help Immune System Clear Glioblastoma

May 18, 2023Cancer ImmunotherapyAAV-Based Immunotherapy, AAV-LIGHT therapy, Glioblastomabiolabs

Glioblastomas are aggressive brain tumors that are largely resistant to immunotherapy, perhaps related to immunosuppression and dysfunctional tumor vasculature, which tend to impede T-cell infiltration. LIGHT, which is also known as tumorRead More…

01Jan/23

Key Molecular Targets Identified for Fighting Against Human Pancreatic Cancer

January 1, 2023Cancer ImmunotherapyCancer Immunotherapybiolabs

Today, pancreatic cancer remains one of the most lethal malignancies facing the global population. The 5-year survival rate for patients with pancreatic ductal adenocarcinoma (PDAC) is only about 3%, and PDAC isRead More…

12Dec/22

The Role of Tumor-Associated Fibroblasts in Inflammation and Antitumor Immunity

December 12, 2022Cancer ImmunotherapyCancer Immunotherapybiolabs

Tumor-associated inflammation (TAI) is an important hallmark of all cancers and involves all cells in the tumor microenvironment (TME), which describes the entire spectrum of cancer cells, immune cells, endothelial cells, andRead More…

Recent Posts

  • Combining Oncolytic Viruses with T-cell Therapy Enhances Cancer Treatment
  • Swine Pseudorabies Virus Attenuated Vaccine Shows Potential for Oncolytic Therapy Against Malignant Tumors
  • Oncolytic Virus Therapy CAN-3110 Shows Promise in Treating Aggressive Brain Cancer Glioblastoma
  • Research Reveals New Mechanism of Oncolytic Virus M1 Enhancing DC Vaccine’s Anti-Tumor Effect
  • Oncolytic Viruses Can Induce A “Cold” Tumor to Heat Up and Improve the Efficiency of Immunotherapy in Treating Cancer

Archives

  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • November 2020

Contact Us

USA – UK

Copyright © Creative Biolabs Oncolytic Virotherapy
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Oncolytic Virus Research
  • Oncolytic Virus News